Development of a Large Scale Process for the Conversion of Polysialogangliosides to Monosialotetrahexosylganglioside with a Novel Strain of Brevibacterium Casei Producing Sialidase.

Yan-Feng Peng,Xue-Dong Wang,Dong-Zhi Wei
DOI: https://doi.org/10.1007/s10529-007-9339-0
2007-01-01
Biotechnology Letters
Abstract:A bioconversion process of producing GM1 (monosialotetrahexosylganglioside) on an industrial scale was developed with a novel sialidase-producing strain Brevibacterium casei. The sialidase hydrolyzed polysialogangliosides to produce GM1 but did not act on GM1. When Brevibacterium casei was cultured in a synthetic medium containing crude pig brain gangliosides (10% w/v) at 30°C for 24 h in a 50 l fermenter, most of the polysialogangliosides were converted to GM1. The content of GM1 was increased from 9% in crude gangliosides to 45% with 70% (w/w) yield.
What problem does this paper attempt to address?